Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ara Unanyan, Laura Pivazyan, Ekaterina Krylova, Andrey Eskin, Araksya Zakaryan, Antonina Sarkisova & Anatoly Ishchenko. (2022) Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis. Gynecological Endocrinology 38:12, pages 1035-1046.
Read now
Read now
Xiaoying Yuan, Qi Huang, Jing Li, Qu Yao, Han Zhang, Qian Wang, Lin Zhang, Ying Zhang, Gangyi Yang, Ling Li & Xin Liao. (2022) Bone morphogenetic protein-9 maybe an important factor which improves insulin resistance in PCOS. Gynecological Endocrinology 38:9, pages 781-789.
Read now
Read now
Priyanka Prabhakar, Reeta Mahey, Monica Gupta, Rajesh Khadgawat, Garima Kachhawa, Jai Bhagwan Sharma, Perumal Vanamail, Rajesh Kumari & Neerja Bhatla. (2021) Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles - randomized controlled trial. Gynecological Endocrinology 37:4, pages 332-336.
Read now
Read now
Fabio Facchinetti, Marialuisa Appetecchia, Cesare Aragona, Arturo Bevilacqua, Maria Salome Bezerra Espinola, Mariano Bizzarri, Rosario D’Anna, Didier Dewailly, Evanthia Diamanti-Kandarakis, Imelda Hernández Marín, Zdravko A. Kamenov, Eleni Kandaraki, Antonio Simone Laganà, Giovanni Monastra, Mario Montanino Oliva, John E. Nestler, Francesco Orio, Ali Cenk Ozay, Olga Papalou, Lali Pkhaladze, Giusy Porcaro, Nikos Prapas, Christophe O. Soulage, Annarita Stringaro, Artur Wdowiak & Vittorio Unfer. (2020) Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond. Expert Opinion on Drug Metabolism & Toxicology 16:3, pages 255-274.
Read now
Read now
Articles from other publishers (18)
Nguyen Sa Viet Le, Minh Tam Le & Thanh Ngoc Cao. (2023) Myo-inositol versus metformin effects on clinical features, endocrine and metabolic profiles in infertile women with polycystic ovary syndrome: A randomized controlled trial. Asian Pacific Journal of Reproduction 12:6, pages 256-265.
Crossref
Crossref
Kaneez Fatima, Zainab Jamil, Samar Faheem, Alishba Adnan, Syed Sarmad Javaid, Hafsa Naeem, Neha Mohiuddin, Anosha Sajid & Sidhant Ochani. (2023) Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis. Irish Journal of Medical Science (1971 -) 192:6, pages 2801-2808.
Crossref
Crossref
Roshan Nazirudeen, Subbiah Sridhar, Raghavendran Priyanka, Baskaran Sumathi, Vasanthiy Natarajan, Eagappan Subbiah, Kasthuri Santharam Raghavan & Jayaraman Sangumani. (2023) A randomized controlled trial comparing myoinositol with metformin versus metformin monotherapy in polycystic ovary syndrome. Clinical Endocrinology 99:2, pages 198-205.
Crossref
Crossref
Zdravko Kamenov & Mario Montanino Oliva. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
65
72
.
Jasmine Dhaliwal. (2022) Comparing Metformin, Inositol, and Lifestyle Modifications to Improve Symptomatology of Polycystic Ovary Syndrome (PCOS): A Research Protocol. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal 6:11, pages 1-8.
Crossref
Crossref
Ruela Joyce L Sigue & Ditas D Decena. (2022) Efficacy of Myo-inositol in Improving Pregnancy Rate and Regulation of Menstrual Cycle for Patients With Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis. Journal of Medicine, University of Santo Tomas 6:2, pages 979-998.
Crossref
Crossref
M. S. Titova, M. I. Kolodina, A. S. Lyashenko & E. N. Lyashenko. (2022) Use of myo-inositol in women with polycystic ovary syndrome in the application of auxiliary reproductive technologies. Meditsinskiy sovet = Medical Council:16, pages 50-56.
Crossref
Crossref
Meysam Zarezadeh, Azadeh Dehghani, Amir Hossein Faghfouri, Nima Radkhah, Mohammad Naemi Kermanshahi, Fatemeh Hamedi Kalajahi, Niyaz Mohammadzadeh Honarvar, Zohreh Ghoreishi, Alireza Ostadrahimi & Mehrangiz Ebrahimi Mamaghani. (2021) Inositol supplementation and body mass index: A systematic review and meta‐analysis of randomized clinical trials. Obesity Science & Practice 8:3, pages 387-397.
Crossref
Crossref
Christos Chatzakis, Evangelia Tsakmaki, Aggeliki Psomiadou, Nikolaos Charitakis, Makarios Eleftheriades, Konstantinos Dinas, Dimitrios Goulis & Alexandros Sotiriadis. (2022) Different pregnancy outcomes according to the polycystic ovary syndrome diagnostic criteria: a systematic review and meta-analysis of 79 studies. Fertility and Sterility 117:4, pages 854-881.
Crossref
Crossref
Reem Magzoub, Elrasheid A.H. Kheirelseid, Claire Perks & Sarah Lewis. (2022) Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology 271, pages 38-62.
Crossref
Crossref
Philippe Merviel, Pandora James, Sarah Bouée, Mathilde Le Guillou, Camille Rince, Charlotte Nachtergaele & Véronique Kerlan. (2021) Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. Reproductive Health 18:1.
Crossref
Crossref
Yuqi Liu, Juan Li, Zhe Yan, Dan Liu, Jinfang Ma & Nanwei Tong. (2021) Improvement of Insulin Sensitivity Increases Pregnancy Rate in Infertile PCOS Women: A Systemic Review. Frontiers in Endocrinology 12.
Crossref
Crossref
Krystallenia I Alexandraki, Eleni A Kandaraki, Kalliopi-Anna Poulia, Christina Piperi, Eirini Papadimitriou & Theodoros G Papaioannou. (2021) Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome. European Endocrinology 1:1, pages 37.
Crossref
Crossref
Aslı Yaylalı, Murat Bakacak & Zeyneb Bakacak. (2021) The efficacy of different insulin-sensitizing agents on treatment outcomes in patients with polycystic ovary syndrome who underwent in-vitro fertilization: A retrospective, record-based, comparative study. Journal of Gynecology Obstetrics and Human Reproduction 50:1, pages 102006.
Crossref
Crossref
Andrea Cignarella, Roberto Mioni, Chiara Sabbadin, Francesca Dassie, Matteo Parolin, Roberto Vettor, Mattia Barbot & Carla Scaroni. (2020) Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS. International Journal of Molecular Sciences 21:24, pages 9554.
Crossref
Crossref
Eser Colak, Emel Ebru Ozcimen, Yusuf Aytac Tohma & Mehmet Ufuk Ceran. (2020)
May myo‐inositol and
d
‐chiro‐inositol (40:1) treatment be a good option on normal‐weighted polycystic ovary syndrome patients without insulin resistance?
. Journal of Obstetrics and Gynaecology Research 46:12, pages 2605-2611.
Crossref
Crossref
Zdravko Kamenov & Antoaneta Gateva. (2020) Inositols in PCOS. Molecules 25:23, pages 5566.
Crossref
Crossref
Fabio Facchinetti, Vittorio Unfer, Didier Dewailly, Zdravko A. Kamenov, Evanthia Diamanti-Kandarakis, Antonio Simone Laganà, John E. Nestler & Christophe O. Soulage. (2020) Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. Trends in Endocrinology & Metabolism 31:6, pages 435-447.
Crossref
Crossref